Olivier Bourron

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny et al. · Diabetologia · 2020 · 830 citations · Full text

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

Agnès Hartemann, G. Bensimon, Christine Payan et al. · The Lancet Diabetes & Endocrinology · 2013 · 414 citations

Inflammation, Metabolic Syndrome, Type 1 +9

Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes

Anaïs Szpigel, Isabelle Hainault, Aurélie Carlier et al. · Diabetologia · 2017 · 133 citations · Full text

Inflammation, Metabolic Syndrome, Immune Cells +11

Lipid droplet analysis in caveolin-deficient adipocytes: alterations in surface phospholipid composition and maturation defects

Cédric M. Blouin, Soazig Le Lay, Anita Eberl et al. · Journal of Lipid Research · 2009 · 110 citations · Full text

Lipid Analysis, Caveolin-deficient Adipocytes, Lipid Movement +18

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

Jean‐Daniel Lalau, Abdallah Al‐Salameh, Samy Hadjadj et al. · Diabetes & Metabolism · 2020 · 93 citations · Full text

Metabolic Syndrome, Reduced Risk, Diabetes Management +11